Gene Therapy Shows Promise for Cutting LDL in Half in Tough-to-Treat Dyslipidemia – MedPage Today

  1. Gene Therapy Shows Promise for Cutting LDL in Half in Tough-to-Treat Dyslipidemia  MedPage Today
  2. How a ‘one and done’ gene-editing treatment could lower cholesterol  The Washington Post
  3. CRISPR Therapeutics (Nasdaq: CRSP) announces 73% ANGPTL3…

Continue Reading